Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 25, 2023

BUY
$2.03 - $4.28 $1,228 - $2,589
605 Added 23.82%
3,145 $0
Q3 2022

Oct 25, 2022

BUY
$3.04 - $5.14 $1,295 - $2,189
426 Added 20.15%
2,540 $8,000
Q2 2022

Aug 04, 2022

BUY
$3.17 - $6.17 $6,701 - $13,043
2,114 New
2,114 $8,000
Q4 2021

Feb 01, 2022

SELL
$10.83 - $18.41 $2,783 - $4,731
-257 Closed
0 $0
Q3 2021

Oct 15, 2021

BUY
$13.07 - $18.84 $3,358 - $4,841
257 New
257 $5,000
Q2 2020

Aug 05, 2020

SELL
$16.86 - $23.44 $1,095 - $1,523
-65 Closed
0 $0
Q1 2020

May 05, 2020

SELL
$14.47 - $27.96 $1,403 - $2,712
-97 Reduced 59.88%
65 $1,000
Q4 2019

Feb 14, 2020

SELL
$15.87 - $23.12 $7,522 - $10,958
-474 Reduced 74.53%
162 $3,000
Q3 2019

Nov 14, 2019

SELL
$16.91 - $36.27 $6,831 - $14,653
-404 Reduced 38.85%
636 $12,000
Q2 2019

Aug 07, 2019

BUY
$31.0 - $36.3 $29,326 - $34,339
946 Added 1006.38%
1,040 $37,000
Q1 2019

May 14, 2019

SELL
$31.58 - $46.35 $5,652 - $8,296
-179 Reduced 65.57%
94 $3,000
Q4 2018

Feb 14, 2019

BUY
$30.43 - $56.65 $5,690 - $10,593
187 Added 217.44%
273 $9,000
Q3 2018

Nov 14, 2018

BUY
$46.46 - $68.49 $2,230 - $3,287
48 Added 126.32%
86 $5,000
Q2 2018

Aug 14, 2018

SELL
$46.25 - $104.45 $1,017 - $2,297
-22 Reduced 36.67%
38 $2,000
Q1 2018

May 15, 2018

BUY
$57.4 - $108.44 $3,444 - $6,506
60 New
60 $6,000

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $174M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.